Skip to main content

Peer Review reports

From: Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patients

Original Submission
8 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
14 Dec 2022 Reviewed Reviewer Report
27 Feb 2023 Reviewed Reviewer Report
5 Apr 2023 Author responded Author comments - Hélène Pluchart
Resubmission - Version 5
5 Apr 2023 Submitted Manuscript version 5
26 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
9 May 2023 Editorially accepted
23 Jun 2023 Article published 10.1186/s12885-023-10939-7

You can find further information about peer review here.

Back to article page